NanoString Technologies, Inc. (NSTG)
| Previous close | 9.11 |
| Open | 9.29 |
| Bid | 9.11 x 900 |
| Ask | 9.12 x 800 |
| Day's range | 8.99 - 9.36 |
| 52-week range | 4.37 - 37.06 |
| Volume | |
| Avg. volume | 684,508 |
| Market cap | 431.016M |
| Beta (5Y monthly) | 1.61 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.82 |
| Earnings date | 10 Apr 2023 - 14 Apr 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 16.57 |
- Business Wire
NanoString Reports Inducement Grants Under Nasdaq Listing Rules
SEATTLE, March 08, 2023--NanoString Technologies, Inc. (Nasdaq: NSTG), a leading provider of life science tools for discovery and translational research, today announced, as required by Nasdaq Stock Market Rules, equity inducement awards to 16 new employees.
- Simply Wall St.
NanoString Technologies Full Year 2022 Earnings: EPS Misses Expectations
NanoString Technologies ( NASDAQ:NSTG ) Full Year 2022 Results Key Financial Results Revenue: US$127.3m (down 12% from...
- Business Wire
NanoString to Webcast Panel on AI-Based Genomics and Drug Discovery from the 43rd Annual Cowen Health Care Conference
SEATTLE, March 01, 2023--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to participate in a panel discussion, "AI-Driven Disruptions To Genomics & Computational Drug Discovery", from the 43rd Annual Cowen Health Care Conference. The conference will be held March 6-8, 2023.
